Pharmacokinetics | Drug Distribution

Name: Pharmacokinetics | Drug Distribution
Uploaded: 2022-07-29T14:19:54.000Z
Duration: 58 min 39 s

Understanding Drug Absorption and Distribution

Overview of Drug Absorption

The process of drug absorption involves the movement of a drug across membranes into the bloodstream, particularly when not administered intravenously.

Key factors influencing absorption include bioavailability and first-pass metabolism, which significantly affect how much of the drug reaches systemic circulation.

Mechanisms of Drug Distribution

Once in the bloodstream, drugs must be distributed to various tissues and organs to exert their effects; this process is known as distribution.

Blood flow is a critical factor affecting distribution; organs with higher blood flow (e.g., kidneys, liver, brain) receive more drug delivery compared to those with lower blood flow.

Impact of Blood Flow on Distribution

Increased blood flow theoretically enhances drug distribution to tissues, while decreased blood flow can limit it.

Clinical conditions like shock (septic, cardiogenic, hypovolemic) can reduce blood flow and subsequently decrease drug delivery to tissues.

Role of Capillary Permeability

Capillary permeability significantly influences how well drugs distribute into tissues; certain capillaries (e.g., sinusoidal in liver/spleen) are more permeable than others.

Sinusoidal and fenestrated capillaries allow easier passage for drugs due to larger pores and fewer tight junctions compared to continuous capillaries found in muscles or the brain.

Factors Affecting Drug Movement Across Capillaries

In less permeable capillaries (like those in the brain), drug diffusion relies on specific transporters or requires drugs to be highly lipid-soluble and small.

Understanding Septic Shock and Drug Distribution

The Impact of Septic Shock on Drug Concentration

Septic shock leads to extreme increases in capillary permeability, referred to as capillary leak syndrome, affecting drug distribution.

Increased capillary permeability results in a decrease in serum concentration of drugs, which is critical for effective treatment in septic patients.

High serum concentrations of antibiotics are necessary for critically ill individuals due to the high distribution and leakage into tissues.

Administering large doses of antibiotics is essential to achieve adequate blood concentrations for therapeutic effects in septic patients.

Key concepts include: increased blood flow enhances drug distribution while decreased blood flow reduces it; leaky capillaries increase distribution.

Factors Affecting Drug Distribution

Protein Binding Dynamics

Protein binding, particularly plasma protein binding (e.g., albumin), significantly influences drug delivery to organs and tissues.

Normal liver and kidney function maintain appropriate levels of albumin, preventing its excretion into urine and ensuring effective drug binding.

High protein-bound drugs result in lower free drug concentrations available for tissue distribution, impacting overall efficacy.

Reservoir Effect of Protein-Bound Drugs

When a drug is highly protein-bound, the amount available for distribution decreases, leading to reduced effectiveness at target sites.

Highly bound drugs tend to concentrate in plasma; however, they can act as reservoirs that release free drug over time as concentrations drop.

Example: Phenytoin's Mechanism

Phenytoin serves as an example where its high albumin-binding allows it to inhibit seizure activity by gradually releasing free drug into circulation.

As phenytoin is metabolized and excreted, the bound form acts as a reservoir that maintains therapeutic levels longer.

Understanding Drug Distribution and Plasma Proteins

The Role of Plasma Proteins in Drug Distribution

Decreased plasma protein levels lead to increased free drug availability, which can enhance drug distribution into tissues. This is crucial for understanding pharmacokinetics.

Albumin, a major plasma protein, cannot easily cross blood vessel walls due to its large size and charge, limiting its ability to move from the bloodstream into tissues.

When drugs are bound to plasma proteins like albumin, their distribution is restricted; only unbound (free) drugs can pass through blood vessel membranes into interstitial spaces.

Clinical Implications of Low Albumin Levels

In chronic kidney disease (CKD), albumin levels drop as it is lost in urine, resulting in higher concentrations of free drugs that can distribute widely and potentially cause toxicity.

Liver diseases such as cirrhosis also reduce albumin production, leading to similar effects: increased free drug levels and risk of adverse effects due to enhanced tissue concentration.

Solubility and Its Impact on Drug Distribution

Drug solubility affects its ability to cross cell membranes; hydrophilic or charged molecules struggle compared to small, nonpolar (lipid-soluble) drugs that can easily diffuse across barriers.

High protein binding typically results in lower distribution of the drug within the body since larger or polar compounds remain trapped in the bloodstream rather than entering tissues.

Volume of Distribution Explained

The volume of distribution (Vd) represents how extensively a drug disperses throughout body fluids; a high Vd indicates widespread distribution beyond just plasma volume.

Understanding Volume of Distribution in Pharmacology

Factors Influencing Volume of Distribution

The volume of distribution (Vd) is affected by blood flow, capillary permeability, protein binding, and solubility. Low blood flow to tissues results in low drug distribution.

High plasma protein binding (e.g., to albumin) decreases the free concentration of a drug available for distribution into tissues, limiting its therapeutic effect.

Hydrophilic drugs that are large, charged, or polar struggle to leave the bloodstream and enter tissue spaces due to their physical properties.

Drug Compartmentalization

A theoretical example illustrates that if a drug occupies only 4 liters of plasma out of a total 24 liters (plasma + interstitial fluid + cells), it has a low Vd and remains concentrated in the plasma.

Key factors contributing to this scenario include high protein binding and decreased capillary permeability.

Comparison of Drug Properties

Another drug with less protein binding and lower molecular weight can distribute more effectively into interstitial spaces, occupying both plasma and interstitial fluid compartments.

This second drug's Vd could be estimated at 12 liters as it occupies both the plasma (4 liters) and interstitial fluid (8 liters).

High Volume of Distribution Drugs

Drugs with minimal protein binding that are small, non-polar, lipid-soluble can easily diffuse into all body compartments due to increased blood flow and capillary permeability.

Such drugs may have an estimated Vd close to 24 liters, indicating extensive distribution throughout body fluids.

Real-world Example: Warfarin

Understanding Volume of Distribution in Pharmacokinetics

The Role of Volume of Distribution

Warfarin is characterized by a low volume of distribution, which allows it to concentrate primarily in blood plasma, effectively acting as a blood thinner by inhibiting clotting proteins.

A contrasting example is chloroquine, which has an extremely high volume of distribution (150,000 liters), indicating its extensive tissue binding rather than plasma protein binding.

Chloroquine's hydrophobic nature and small size enable it to distribute widely throughout body tissues, making it effective against malaria.

Understanding the concept of volume of distribution is crucial for determining how drugs exert their effects in specific areas within the body.

Factors Influencing Drug Distribution

Bioavailability is a key concept; for instance, a drug with high molecular weight and extensive protein binding will have poor distribution due to remaining in the vascular system.

A large molecule that is hydrophilic and heavily protein-bound will exhibit low volume of distribution because it cannot easily exit the bloodstream into tissues.

Conversely, smaller and less protein-bound molecules tend to have higher volumes of distribution due to their ability to permeate tissues more readily.

Case Study: Vancomycin Administration

A case involving a 40-year-old male patient diagnosed with MRSA illustrates practical application; he received a 2000 mg loading dose of vancomycin.

The peak plasma concentration achieved was 28.5 mg/L; using this data helps calculate the apparent volume of distribution based on bioavailability and dosage.

With intravenous administration (100% bioavailability), the calculation yields approximately 70.1 liters as the total volume distributed throughout body compartments.

Conclusion on Volume Calculation

When adjusted for body weight (70 kg), the apparent volume of distribution comes out to about 1 liter per kg, highlighting significant pharmacokinetic principles at play.